Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of HLA-DQA1*05 Genotype in Adults With Inflammatory Bowel Disease and Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring. A Prospective Multicenter Study.

NCT05986903 is registered in ClinicalTrials.gov with Hospital del Rio Hortega as lead sponsor.

NCT NCT05986903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05986903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of HLA-DQA1*05 Genotype in Adults With Inflammatory Bowel Disease and Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring. A Prospective Multicenter Study.
Lead sponsor
Hospital del Rio Hortega
Phase
Observational
Overall status
Unknown status
Start date
January 11, 2023
Completion date
January 1, 2025
Enrollment
280 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug monitoring, inflammatory bowel diseases